Literature DB >> 33446877

Integrated, automated maintenance, expansion and differentiation of 2D and 3D patient-derived cellular models for high throughput drug screening.

Ibrahim Boussaad1,2, Gérald Cruciani1,2, Silvia Bolognin3, Paul Antony1,2, Claire M Dording2,4, Yong-Jun Kwon2,5, Peter Heutink6, Eugenio Fava7, Jens C Schwamborn3, Rejko Krüger8,9,10,11.   

Abstract

Patient-derived cellular models become an increasingly powerful tool to model human diseases for precision medicine approaches. The identification of robust cellular disease phenotypes in these models paved the way towards high throughput screenings (HTS) including the implementation of laboratory advanced automation. However, maintenance and expansion of cells for HTS remains largely manual work. Here, we describe an integrated, complex automated platform for HTS in a translational research setting also designed for maintenance and expansion of different cell types. The comprehensive design allows automation of all cultivation steps and is flexible for development of methods for variable cell types. We demonstrate protocols for controlled cell seeding, splitting and expansion of human fibroblasts, induced pluripotent stem cells (iPSC), and neural progenitor cells (NPC) that allow for subsequent differentiation into different cell types and image-based multiparametric screening. Furthermore, we provide automated protocols for neuronal differentiation of NPC in 2D culture and 3D midbrain organoids for HTS. The flexibility of this multitask platform makes it an ideal solution for translational research settings involving experiments on different patient-derived cellular models for precision medicine.

Entities:  

Year:  2021        PMID: 33446877      PMCID: PMC7809482          DOI: 10.1038/s41598-021-81129-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  40 in total

1.  Utilizing Low-Volume Aqueous Acoustic Transfer with the Echo 525 to Enable Miniaturization of qRT-PCR Assay.

Authors:  Sony Agrawal; Steven Cifelli; Richard Johnstone; David Pechter; Deborah A Barbey; Karen Lin; Tim Allison; Shree Agrawal; Aida Rivera-Gines; James A Milligan; Jonathan Schneeweis; Kevin Houle; Alice J Struck; Richard Visconti; Matthew Sills; Mary Jo Wildey
Journal:  J Lab Autom       Date:  2015-10-12

2.  Bioreactor design for successive culture of anchorage-dependent cells operated in an automated manner.

Authors:  Masahiro Kino-Oka; Natsuki Ogawa; Ryota Umegaki; Masahito Taya
Journal:  Tissue Eng       Date:  2005 Mar-Apr

Review 3.  How were new medicines discovered?

Authors:  David C Swinney; Jason Anthony
Journal:  Nat Rev Drug Discov       Date:  2011-06-24       Impact factor: 84.694

Review 4.  Stem Cells, Genome Editing, and the Path to Translational Medicine.

Authors:  Frank Soldner; Rudolf Jaenisch
Journal:  Cell       Date:  2018-10-18       Impact factor: 41.582

5.  Towards optimisation of induced pluripotent cell culture: Extracellular acidification results in growth arrest of iPSC prior to nutrient exhaustion.

Authors:  Anja Wilmes; Caroline Rauch; Giada Carta; Georg Kern; Florian Meier; Wilfried Posch; Doris Wilflingseder; Lyle Armstrong; Majlinda Lako; Mario Beilmann; Gerhard Gstraunthaler; Paul Jennings
Journal:  Toxicol In Vitro       Date:  2017-08-15       Impact factor: 3.500

6.  Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson's disease.

Authors:  Heather Mortiboys; Jan Aasly; Oliver Bandmann
Journal:  Brain       Date:  2013-09-02       Impact factor: 13.501

7.  Establishment of automated culture system for murine induced pluripotent stem cells.

Authors:  Hiroyuki Koike; Koji Kubota; Keisuke Sekine; Takanori Takebe; Rie Ouchi; Yun-Wen Zheng; Yasuharu Ueno; Naoki Tanigawa; Hideki Taniguchi
Journal:  BMC Biotechnol       Date:  2012-11-05       Impact factor: 2.563

8.  Comparability of automated human induced pluripotent stem cell culture: a pilot study.

Authors:  Peter R T Archibald; Amit Chandra; Dave Thomas; Olivier Chose; Emmanuelle Massouridès; Yacine Laâbi; David J Williams
Journal:  Bioprocess Biosyst Eng       Date:  2016-08-08       Impact factor: 3.210

9.  Reproducibility of Molecular Phenotypes after Long-Term Differentiation to Human iPSC-Derived Neurons: A Multi-Site Omics Study.

Authors:  Viola Volpato; James Smith; Cynthia Sandor; Janina S Ried; Anna Baud; Adam Handel; Sarah E Newey; Frank Wessely; Moustafa Attar; Emma Whiteley; Satyan Chintawar; An Verheyen; Thomas Barta; Majlinda Lako; Lyle Armstrong; Caroline Muschet; Anna Artati; Carlo Cusulin; Klaus Christensen; Christoph Patsch; Eshita Sharma; Jerome Nicod; Philip Brownjohn; Victoria Stubbs; Wendy E Heywood; Paul Gissen; Roberta De Filippis; Katharina Janssen; Peter Reinhardt; Jerzy Adamski; Ines Royaux; Pieter J Peeters; Georg C Terstappen; Martin Graf; Frederick J Livesey; Colin J Akerman; Kevin Mills; Rory Bowden; George Nicholson; Caleb Webber; M Zameel Cader; Viktor Lakics
Journal:  Stem Cell Reports       Date:  2018-09-20       Impact factor: 7.765

Review 10.  Human iPSC banking: barriers and opportunities.

Authors:  Ching-Ying Huang; Chun-Lin Liu; Chien-Yu Ting; Yueh-Ting Chiu; Yu-Che Cheng; Martin W Nicholson; Patrick C H Hsieh
Journal:  J Biomed Sci       Date:  2019-10-28       Impact factor: 8.410

View more
  5 in total

Review 1.  Human Brain-Based Models Provide a Powerful Tool for the Advancement of Parkinson's Disease Research and Therapeutic Development.

Authors:  Sarah F McComish; Adina N MacMahon Copas; Maeve A Caldwell
Journal:  Front Neurosci       Date:  2022-05-16       Impact factor: 5.152

2.  Operationalizing the Use of Biofabricated Tissue Models as Preclinical Screening Platforms for Drug Discovery and Development.

Authors:  Olive Jung; Min Jae Song; Marc Ferrer
Journal:  SLAS Discov       Date:  2021-07-16       Impact factor: 3.341

3.  Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function.

Authors:  Jochen Ohnmacht; Bruno F R Santos; Peter A Barbuti; Paul M Antony; François Massart; Gérald Cruciani; Claire M Dording; Lukas Pavelka; Nicolas Casadei; Yong-Jun Kwon; Rejko Krüger
Journal:  Sci Rep       Date:  2021-11-09       Impact factor: 4.379

Review 4.  Patient-Derived Organoids as a Model for Cancer Drug Discovery.

Authors:  Colin Rae; Francesco Amato; Chiara Braconi
Journal:  Int J Mol Sci       Date:  2021-03-27       Impact factor: 5.923

Review 5.  Contribution of Human Pluripotent Stem Cell-Based Models to Drug Discovery for Neurological Disorders.

Authors:  Alexandra Benchoua; Marie Lasbareilles; Johana Tournois
Journal:  Cells       Date:  2021-11-24       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.